Rui Lu

Rui Lu, Ph.D., is an Associate Professor of Medicine at the University of Alabama at Birmingham and an Associate Scientist at the O’Neal Comprehensive Cancer Center. He received his Ph.D. from the University of the Chinese Academy of Sciences and completed postdoctoral training at the University of North Carolina at Chapel Hill. Dr. Lu leads a research laboratory focused on deciphering the epigenetic and transcriptional mechanisms that drive cancer, with an emphasis on developing targeted, mechanism-based therapies. His expertise spans chromatin regulation, transcriptional control, leukemia biology, and functional genomics, supported by diverse molecular, cellular, bioinformatic, and in vivo modeling approaches. His independent research program has been recognized by multiple competitive awards from the NCI, ASH, ACS, the Mark Foundation, and others, and has produced a series of high-impact, peer-reviewed publications in the field of leukemia and epigenetics.